Literature DB >> 19508396

Recent advances in arginine metabolism: roles and regulation of the arginases.

Sidney M Morris1.   

Abstract

As arginine can serve as precursor to a wide range of compounds, including nitric oxide, creatine, urea, polyamines, proline, glutamate and agmatine, there is considerable interest in elucidating mechanisms underlying regulation of its metabolism. It is now becoming apparent that the two isoforms of arginase in mammals play key roles in regulation of most aspects of arginine metabolism in health and disease. In particular, work over the past several years has focused on the roles and regulation of the arginases in vascular disease, pulmonary disease, infectious disease, immune cell function and cancer. As most of these topics have been considered in recent review articles, this review will focus more closely on results of recent studies on expression of the arginases in endothelial and vascular smooth muscle cells, post-translational modulation of arginase activity and applications of arginase inhibitors in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508396      PMCID: PMC2737650          DOI: 10.1111/j.1476-5381.2009.00278.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  90 in total

1.  Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles.

Authors:  Naris Thengchaisri; Travis W Hein; Wei Wang; Xin Xu; Zhenbo Li; Theresa W Fossum; Lih Kuo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-06-22       Impact factor: 8.311

2.  Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. Role in polyamine biosynthesis.

Authors:  W Durante; L Liao; K J Peyton; A I Schafer
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

3.  Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats.

Authors:  Céline Demougeot; Anne Prigent-Tessier; Christine Marie; Alain Berthelot
Journal:  J Hypertens       Date:  2005-05       Impact factor: 4.844

4.  Physiological cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle.

Authors:  W Durante; L Liao; S V Reyna; K J Peyton; A I Schafer
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

5.  Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries.

Authors:  Renzo Y Loyaga-Rendon; Shuichi Sakamoto; Masashi Beppu; Takeshi Aso; Mihoko Ishizaka; Ryoko Takahashi; Hiroshi Azuma
Journal:  Atherosclerosis       Date:  2005-02       Impact factor: 5.162

6.  Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.

Authors:  Louis G Chicoine; Michael L Paffett; Tamara L Young; Leif D Nelin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

7.  Cytochrome P450 catalyzes the oxidation of N omega-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrulline.

Authors:  J L Boucher; A Genet; S Vadon; M Delaforge; Y Henry; D Mansuy
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

8.  Arginase and autoimmune inflammation in the central nervous system.

Authors:  Lingyun Xu; Brendan Hilliard; Ruaidhrí J Carmody; Galit Tsabary; Hyunshun Shin; David W Christianson; Youhai H Chen
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

Review 9.  Arginine metabolism: boundaries of our knowledge.

Authors:  Sidney M Morris
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

Review 10.  Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling.

Authors:  Masataka Mori
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

View more
  159 in total

1.  Endothelial arginase II responds to pharmacological inhibition by elevation in protein level.

Authors:  Karina Krotova; Jawaharlal M Patel; Edward R Block; Sergey Zharikov
Journal:  Mol Cell Biochem       Date:  2010-06-19       Impact factor: 3.396

2.  Role of arginase in impairing relaxation of lung parenchyma of hyperoxia-exposed neonatal rats.

Authors:  Nuzhat K M Ali; Anjum Jafri; Ramadan B Sopi; Y S Prakash; Richard J Martin; Syed I A Zaidi
Journal:  Neonatology       Date:  2011-09-23       Impact factor: 4.035

3.  Arginase II inhibition prevents nitrate tolerance.

Authors:  S M L Khong; K L Andrews; N N Huynh; K Venardos; A Aprico; D L Michell; M Zarei; K T Moe; G J Dusting; D M Kaye; J P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 4.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

5.  Arginase-2 mediates renal ischemia-reperfusion injury.

Authors:  Wesley M Raup-Konsavage; Ting Gao; Timothy K Cooper; Sidney M Morris; W Brian Reeves; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

6.  Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors.

Authors:  Roman Blaszczyk; Joanna Brzezinska; Barbara Dymek; Paulina S Stanczak; Marcin Mazurkiewicz; Jacek Olczak; Julita Nowicka; Karolina Dzwonek; Agnieszka Zagozdzon; Jakub Golab; Adam Golebiowski
Journal:  ACS Med Chem Lett       Date:  2020-03-13       Impact factor: 4.345

7.  Impaired T cell function in argininosuccinate synthetase deficiency.

Authors:  Tatyana N Tarasenko; Julio Gomez-Rodriguez; Peter J McGuire
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

Review 8.  Molecular mechanisms underlying the activation of eNOS.

Authors:  Ingrid Fleming
Journal:  Pflugers Arch       Date:  2009-12-13       Impact factor: 3.657

9.  Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.

Authors:  Maria Dulfary Sanchez; Augusto C Ochoa; Timothy P Foster
Journal:  Antiviral Res       Date:  2016-05-15       Impact factor: 5.970

10.  Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.

Authors:  Rance Nault; Kelly A Fader; Dustin A Ammendolia; Peter Dornbos; Dave Potter; Bonnie Sharratt; Kazuyoshi Kumagai; Jack R Harkema; Sophia Y Lunt; Jason Matthews; Tim Zacharewski
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.